Software S Scaling Biotech
Drug discovery is built around lousy data
I’ve been exploring how the relationship between the newest generation of digital models and the drug discovery process is different compared to older models.
The latest biotech and pharma news from the trade press, updated every hour and linked straight to the publisher. Follow funding, clinical, deals and more. Every story links straight to its publisher.
Software S Scaling Biotech
I’ve been exploring how the relationship between the newest generation of digital models and the drug discovery process is different compared to older models.
Agriculture
AgriBusiness Global
Rafael Ughini Villarroel will assume the position of Region President, Brazil, effective January 1, 2027. The post Albaugh Announces Leadership Transition in Brazil appeared first on AgriBusiness Global.
Regulatory
STAT Biotech
GSK has won FDA approval for its hepatitis B drug, which extended functional cures to far more patients than previous methods.
Industry
BioPharma Dive
New follow-up results suggest Arcus’ drug might be superior to a marketed Merck medicine. Elsewhere, Eli Lilly and AstraZeneca forged new partnerships.
Industry
GEN
In this GEN webinar, our expert speaker, Arati Naveen, PhD, will trace the foundational discoveries that shaped organoid technology as a new approach methodology (NAM), while highlighting pioneering contributions and contemporary advances. The post The Organoid Odyssey: A Glimpse…
Manufacturing B BioPharm International
Backed by €400 million (US$449 million) in EU-cleared German aid, the new Frankfurt facility is designed to secure insulin supply for people with diabetes from 2032.
Regulatory
Pharmaceutical Technology
GSK's likely blockbuster-to-be led to a fifth of patients having undetectable viral levels in clinical trials.
Industry P Pharmaceutical Commerce
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how automation cuts human touches, enforces quarantine and consolidates cold storage.
Industry P Pharmaceutical Executive
Median net launch prices for new drugs climbed between 2022 and 2025 to $257,000, according to a new ICER and West Health report that also found persistent coverage and access barriers for patients.
Industry G GCBR Organization Updates
Updates from CLTR, Coefficient Giving, Mirror Biology Dialogues Fund, CSR, IGSC, Blueprint Biosecurity, FAI, and RAND CAST
Industry P PLOS Biology
by Huimin Liu, Yuzhen Wang, Ruiqing Yu, Kexin Liu, Dezhi Zheng, Bo Wang, Yuan Chang, Bing Liu, Xuetian Yue, Zhuanchang Wu, Chunyang Li, Xiaohong Liang, Chunhong Ma, Guohua Liu, Jianhua Li, Leiqi Xu, Lifen Gao Macrophages play a pivotal role in the pathogenesis of inflammatory bow…
Industry P PLOS Biology
by Yi Qiu, Emilie Hebraud, Fanny Pouyet, Alexander F. Palazzo In the human genome, mutation rates vary along genes, yet how their fine-scale structure contributes to gene evolution has remained largely unexplored. Here, we map inherited mutations at single-nucleotide resolution a…
Industry
Clinical Trials Arena
The post Covid-19 and international aid cuts disrupt tuberculosis care in South Africa appeared first on Clinical Trials Arena.
Regulatory P Pharmaceutical Executive
The FDA approved GSK's bepirovirsen for adults with chronic hepatitis B on nucleoside therapy, based on phase 3 trials showing 19% functional cure.
Clinical B BioPharm International
EA2251, the 7th registrational trial of ivonescimab, will test it plus chemotherapy vs pembrolizumab or durvalumab regimens in first-line BTC.
Industry
Inside Precision Medicine
A new CAIX-targeted PET imaging agent detected nearly all clear cell kidney cancer lesions, outperforming FDG PET and changing treatment decisions in more than one-third of patients. The post New PET Imaging Changes Care in Clear Cell Kidney Cancer appeared first on Inside Precis…
Agriculture
Global Ag Tech Initiative
Kubota North America has announced the next phase of its strategic collaboration with Agtonomy, an award-winning agricultural autonomy […] The post Kubota Expands Autonomous Solutions and Introduces the M5L Tractor for Specialty Crops appeared first on Global Ag Tech Initiative.
Industry
BioSpace
Looking for a remote biopharma position? Check out the BioSpace list of eight companies hiring life sciences professionals like you.
Industry
Inside Precision Medicine
In this Behind the Breakthroughs, the Clinical Genomics Lab co-director discusses how gene fusion detection is raising the bar for precision oncology and cancer diagnostics and the evolving genomic testing landscape. The post Hussam Al Kateb: Inside Mayo Clinic’s Molecular Diagno…
Industry P Pharmaceutical Executive
Deborah Waterhouse is leaving ViiV Healthcare to become CEO and managing director of CSL.
Software
MedTech Dive
Rick Abramson, director of the FDA’s Digital Health Center of Excellence, said to expect draft guidance in the coming months.
Regulatory
PharmaVoice
Dr. Robert Redfield and Dr. Stephen Hahn came aboard Turn Therapeutics this year to help the clinical-stage company develop a platform that could one day change how vaccines are delivered.
Industry
Labiotech
Delve into Labiotech's October oncology roundup and find out about the news that caught our attention this last month. The post Oncology biotech news: key moves to watch in October 2026 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or…
Industry
MedTech Dive
As medical device makers face “finite” capital, portfolio reshaping will likely remain a focus in the sector.
Industry P pharmaphorum
ViiV's Waterhouse exits to take the CEO job at CSL Phil.Taylor Wed, 21/10/2026 - 12:41
Industry
STAT Biotech
An immune drug from Roivant could be headed to a new market, after the company reported positive trials in the eye disease non-infectious uveitis.
Research P pharmaphorum
CagriSema helps women lose 25% of their weight in study Phil.Taylor Wed, 21/10/2026 - 11:32
Clinical
Clinical Trials Arena
Analysts say that Sanofi and Teva's duvakitug could be differentiated from other pipeline TL1A candidates as the race to market heats up. The post Sanofi & Teva’s IBD drug prompts long-term clinical remission in Phase IIb trial appeared first on Clinical Trials Arena.
Research B BioTechniques
A teeny-tiny marine microbe with one of the smallest genomes ever discovered is pushing the limits of what it means to be alive. An international team, including researchers from the University of Nottingham (UK) and the University of Tsukuba (Japan), has identified a minuscule m…
Software A Applied Clinical Trials
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination b…
Industry
Pharmaceutical Technology
AbbVie is just one of several pharmaceutical companies to pen sponsorship deals in sport, blurring the commercial line between the two industries.
Regulatory P pharmaphorum
GSK wins FDA green light for chronic hep B treatment Hibsago Phil.Taylor Wed, 21/10/2026 - 10:32
Industry P Pharmafile
Cori Clinical has announced the appointment of Dr Emma Ogburn as Chief Clinical Officer. She joins Cori’s founding team of industry veterans, including CEO Jorn Jansen Schoonhoven (ex-Amazon, IBM) and CTO Patricio Fernadez (ex-Sanofi, AstraZeneca). The firm has recently raised US…
Industry S Science News
Brian Stone and Rebecca Keiser are leaving as unofficial head and chief of staff
Industry
Pharmaceutical Technology
Consolidating complicated supply chains with trusted providers reduces governance, sharpens cost and emissions insight, and creates a more resilient, coordinated network.
Industry P Pharmaceutical Executive
Incubate’s John Stanford on why MFN’s first casualty is the moonshot — and why cancer, Alzheimer’s, and rare disease bear the cost.
Software B BLOPIG
Andrew D. Blevins and Ian K. Quigley, co-founders of Leash Bio, released a pre-print last year that I think deserves some more attention. Using a Bemis-Murcko scaffold split, the authors show that it is possible to train a machine learning model to identify which of 1,815 medicin…
Clinical
Clinical Trials Arena
Amgen and AstraZeneca have reported complete results from the Phase III CROSSING trial of Tezspire for adolescent and adult patients with uncontrolled, symptomatic EoE. The post Amgen and AstraZeneca report Phase III Tezspire data for EoE appeared first on Clinical Trials Arena.
Regulatory
Pharmaceutical Technology
The FDA has granted approval for Cosette’s Evoxac oral solution to treat dry mouth symptoms in adults diagnosed with Sjögren’s disease.